Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing pharmacokinetics, safety, and tolerability of escalating rifapentine doses in healthy volunteers completed with posted results in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• rifapentine (rifapentine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, Tuberculosis, Pulmonary | Phase 1 | Status: COMPLETED | Results posted: 2019-05-07